The present invention relates to C-terminally truncated flavivirus envelope proteins 80-81% in size which are more immunogenic than their counterpart full-length proteins. The present invention further relates to recombinant viruses which encode the truncated protein and to host cells infected therewith....http://www.google.fr/patents/US5494671?utm_source=gb-gplus-shareBrevet US5494671 - C-terminally truncated dengue and Japanese encephalitis virus envelope proteins
C-terminally truncated dengue and Japanese encephalitis virus envelope proteins
